The evaluation of severity of symptoms, tracking complications, choosing effective and efficient approach to treatment, and prognosis is important in benign prostatic enlargement (BPE) patients. Measurement of intravesical prostatic protrusion (IPP) is an easy, affordable and non-invasive marker for benign prostatic obstruction with a high diagnostic value. This study aims to undertake a descriptive review of current literature for the role of IPP in the evaluation and treatment of patients with BPE. Relevant articles written in English language were retrieved from PubMed and Google Scholar. Keywords used for searching articles included intravesical prostatic Protrusion and Benign Prostatic Enlargement/ hyperplasia/ Obstruction; evaluation; and treatment. Papers published between January 1990 and October 2020 were extracted and evaluated. The analyzed studies showed that IPP can be assessed by various modalities and is important in the evaluation of symptom severity, tracking progression and complications of disease, choosing treatment option and prognostication. It is important that IPP be always assessed at the point of initial evaluation of BPE patients.
P. Abrams, L. Cardozo, M. Fall, D. Griffiths, P. Rosier, U. Ulmsten, and et al, “The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society,” Urology, vol. 61, no. 1, pp. 37-49, Jan. 2003.
T. Huang, J. Qi, Y. Yu, D. Xu, Y. Jiao, J. Kang, and et al, “Transitional zone index and intravesical prostatic protrusion in benign prostatic hyperplasia patients: correlations according to treatment received and other clinical data,” Korean J. Urol., vol. 53, no. 4, pp. 253-257, Apr. 2012.
G. B. Sigdel, and W. K. Belokar, “Clinical significance of intravesical prostatic protrusion in patients with benign prostatic hyperplasia,” J. Univ. Coll. Med. Sci., vol. 3, no. 1, pp. 6-10, Sept. 2015.
K. T. Foo, “Decision making in the management of benign prostatic enlargement and the role of transabdominal ultrasound,” Int. J. Urol., vol. 17, no. 12, pp. 974-979, Dec. 2010.
S. H. Shin, J. W. Kim, J. W. Kim, M. M. Oh, and D. G. Moon, “Defining the degree of intravesical prostatic protrusion in association with bladder outlet obstruction,” Korean J. Urol., vol. 54, no. 6, pp. 369-372, Jun. 2013.
L. O. Reis, G. C. Barreiro, J. Baracat, A. Prudente, and C. A. D'Ancona, “Intravesical protrusion of the prostate as a predictive method of bladder outlet obstruction,” Int. Braz. J. Urol., vol. 34, no. 5, pp. 627-637, Oct. 2008.
T. L. Kuo, J. S. Teo, and K. T. Foo, “The role of intravesical prostatic protrusion (IPP) in the evaluation and treatment of bladder outlet obstruction (BOO),” Neurourol. Urodyn., vol. 35, no. 4, pp. 535-537, Apr. 2016.
A. K. M. S. Hossain, A. K. M. K. Alam, A. K. M. K. Habib, M. M. Rashid, H. Rahman, A. K. M. A. Islam, and M. U. Jahan, “Comparison between prostate volume and intravesical prostatic protrusion in detecting bladder outlet obstruction due to benign prostatic hyperplasia” Bangladesh Med. Res. Counc. Bull., vol. 38, no. 1, pp. 14-17, Apr. 2012.
D. Wang, H. Huang, Y. M. Law, and K. T. Foo, “Relationships between prostatic volume and intravesical prostatic protrusion on transabdominal ultrasound and benign prostatic obstruction in patients with lower urinary tract symptoms,” Ann. Acad. Med. Singap., vol. 44, no. 2, pp. 60-65, Feb. 2015.
A. Lee, H. J. Lee, K. B. Lim, H. H. Huang, H. Ho, and K. T. Foo, “Can intravesical prostatic protrusion predict bladder outlet obstruction even in men with good flow?,” Asian J. Urol., vol. 3, no. 1, pp. 39-43, Jan. 2016.
S. K. Reddy, and A. B. Shaik, “Non-invasive evaluation of bladder outlet obstruction in benign prostatic hyperplasia: a clinical correlation study,” Arab J. Urol., vol. 17, no. 4, pp. 259-264, Oct. 2019.
J. Gandhi, S. J. Weissbart, A. N. Kim, G. Joshi, S. A. Kaplan, and S. A. Khan, “Clinical considerations for intravesical prostatic protrusion in the evaluation and management of bladder outlet obstruction secondary to benign prostatic hyperplasia,” Curr. Urol., vol.12, no. 1, pp. 6-12, Oct. 2018.
M. S. Kim, K. K. Park, B. H. Chung, and S. H. Lee, “Effect of photoselective vaporization prostatectomy on lower urinary tract symptoms in benign prostatic hyperplasia with or without intravesical prostatic protrusion,” Korean J. Urol., vol. 54, no. 1, pp. 36-41, Jan. 2013.
H. Y. Park, J. Y. Lee, S. Y. Park, S. W. Lee, Y. T. Kim, H. Y. Choi, and et al, “Efficacy of alpha blocker treatment according to the degree of intravesical prostatic protrusion detected by transrectal ultrasonography in patients with benign prostatic hyperplasia,” Korean J. Urol. Vol. 53, no. 2, pp. 92-97, Feb. 2012.
B. U. Eze, T. U. Mbaeri, C. K. Oranusi, J. A. Abiahu, A. M. Nwofor, J. C. Orakwe, and O. O. Mbonu, “Correlation between intravesical prostatic protrusion and international prostate symptom score among Nigerian men with benign prostatic hyperplasia,” Niger. J. Clin. Pract., vol. 22, no. 4, pp. 454-459, Apr. 2019.
S. P. Yuen, J. T. Ngiap, C. W. Cheng, and K. T. Foo, “Effects of bladder volume on transabdominal ultrasound measurement of intravesical prostatic volume,” Int. J. Urol., vol. 9, no. 4, pp. 225-229, Apr. 2002.
P. Mariappan, D. J. Brown, and A. S. McNeill, “Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study,” J. Urol., vol. 178, no. 2, pp. 573-577, Aug. 2007.
S. W. Lee, J. M. Cho, J. Y. Kang, and T. K. Yoo, “Clinical and urodynamic significance of morphological differences in intravesical prostatic protrusion,” Korean J. Urol., vol. 51, no. 10, pp. 694-699, Oct. 2010.
H. Nose, K. T. Foo, K. B. Lim, T. Yokoyama, H. Ozawa, and H. Kumon, “Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: Intravesical prostatic protrusion and velocity-flow video urodynamics,” Urology, vol. 65, no. 3, Mar. 2005.
W. Huang, J. J. Cao, M. Cao, H. S. Wu, Y. Y. Yang, Z. M. Xu, and X.D. Jin, “Risk factors for bladder calculi in patients with benign prostatic hyperplasia,” Medicine,vol. 96, no. 32, pp. e7728, Aug. 2017.
L. S. Lee, H. G. Sim, K. B. Lim, D. Wang, and K. T. Foo, “Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment,” Int. J, Urol., vol. 17, no. 1, pp. 69-74, Jan. 2010.
C. K. Doo, and H. S. Uh, “Anatomic configuration of prostate obtained by noninvasive ultrasonography can predict clinical voiding parameters for determining BOO in men with LUTS.” Urology, vol. 73, no. 2, pp. 232-236, Feb. 2009.
S.Yang, W. S. Hong, J. M. Lee, T. Kim, H. Chung, H. S. Kim, and et al, “Is intravesical prostatic protrusion associated with predominant and intractable storage symptoms in BPH patients with over 30 g of prostate volume?,” Neurourol. Urodyn., vol. 27, no. 7, pp. 580-581, Sept. 2008.
P. Abrams, C. Chapple, S. Khoury, C. Roehrborn, and J. De la Rosette, “International consultation on new developments in prostate cancer and prostate diseases. Evaluation and treatment of lower urinary tract symptoms in older men,” J. Urol., vol. 189, pp. S93-S101, 2013.
Z. Keqin, X. Zhishun, Z. Jing, W. Haixin, Z. Dongqing, and S. Benkang, “Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement.” Urology, vol. 70, no. 6, pp. 1096-1099, Dec. 2007.
M. J. Barry, F. J. Fowler, M. P. O’Leary, R. C. Bruskewitz, H. L. Holtgrewe, W. K. Mebust, and et al, “The American Urological Association symptom index for benign prostatic hyperplasia,” J. Urol., vol. 148, no.5, pp. 1549-1557, Nov. 1992.
J. M. Lee, H. Chung, T. W. Kim, H. S. Kim, J. H. Wang, and S. K. Yang, “The correlation of intravesical prostatic protrusion with storage symptoms, as measured by transrectal ultrasound,” Korean J. Urol., vol. 49, no. 2, pp. 145-149, Feb, 2008.
C. P. Hou, Y. H. Lin, C. L. Chen, Y. L. Tsai, P. L. Chang, and K. H. Tsui, “Impact of the static prostatic urethral angle on men with lower urinary tract symptoms,” Urol. Sci., vol. 27, no. 1, pp. 47-50, Mar. 2016.
J. Tjahjodjati, and J. Santoso, “Relationship between prostate-urethral angle, intravesical prostatic protrusion, international prostatic symptom score, and uroflowmetry in benign prostatic hyperplasia patients,” Int. J. Integr. Health Sci., vol. 3, no. 2, pp. 50-54, 2015.
Y. M. Seo, and H. J. Kim, “Impact of intravesical protrusion of the prostate in the treatment of lower urinary tract symptoms/benign prostatic hyperplasia of moderate size by alpha receptor antagonist,” Int. Neurourol. J., vol. 16. no. 4, pp. 187-190, Dec. 2012.
S. Guneyli, E. Ward, Y. Peng, A. Nehal Yousuf, I. Trilisky, C. Westin, T. Antic, and A. Oto, “MRI evaluation of benign prostatic hyperplasia: correlation with international prostate symptom score,” J. Magn. Reson. Imaging, vol. 45, no. 3, pp. 917-925, Mar. 2017.
H. K. Park, G. Y. Choo, H. Chung, S. H. Paick, H. G. Kim, H. S. Kim, Y. S. Lho, W. S. Hong, and S. K. YANG, “Effect of intravesical prostatic protrusion on the characteristics of lower urinary tract symptom change after 12‐week drug medication: a prospective analysis,” Low. Urin. Tract Symptoms, vol. 5, no. 1, pp. 1-4, Jan. 2013.
Y. J. Park, K. H. Bae, B. S. Jin, H. J. Jung, and J. S. Park, “Is increased prostatic urethral angle related to lower urinary tract symptoms in males with benign prostatic hyperplasia/lower urinary tract symptoms?,” Korean J. Urol., vol. 53, no. 6, pp. 410-413. Jun, 2012.
C. A. Agbo, V. M. Ramyil, N. K. Dakum, S. I. Shuaibu, V. E. Onowa, L. E. Nabasu, Z. Z. Galam, and B. C. Ukaonu, “The value of intravesical prostatic protrusion in evaluation of bladder outlet obstruction from benign prostatic enlargement in Nigeria,” Afr. J. Urol., vol. 24, no. 4, pp. 342-346, 2018.
M. A. Hossain, M. W. Islam, M. F. Naser, and M. S. Azam, “Correlation of international prostate symptom score With intravesical protrusion of prostate in patients with benign enlargement of prostate,” Bangladesh J. Urol., vol. 22, no. 2, pp. 151-154, Nov. 2019.
J. Zheng, J. Pan, Y. Qin, J. Huang, Y. Luo, X. Gao, and X. Zhou, “Role for intravesical prostatic protrusion in lower urinary tract symptom: a fluid structural interaction analysis study,” BMC Urol., vol. 15, no. 1, pp. 86-86, Dec. 2015. https://doi.org/10.1186/s12894-015-0081-y
T. Yoshida, H. Kinoshita, K. Yoshida, T. Mishima, H. Taniguchi, M. Yanishi, Y. Komai, K. Yasuda, M. Sugi, and T. Matsuda, “Intravesical prostatic protrusion as a predicting factor for the adverse clinical outcome in patients with symptomatic benign prostatic enlargement treated with dutasteride,” Urology, vol.91, pp. 154-157, 2016.
C. H. Lu, H. H. Wu, T. P. Lin, Y. H. Huang, H. J. Chung, J. Y. Kuo, W. J. Huang, S. H. Lu, Y. H. Chang, and A. T. Lin, “Is intravesical prostatic protrusion a risk factor for hydronephrosis and renal insufficiency in benign prostate hyperplasia patients?,” J. Chin. Med. Assoc., vol. 82, no. 5, pp. 381-384, May 2019.
J. W. Kim, M. M. Oh, H. S. Park, J. Cheon, J. G. Lee, J. J. Kim, and D. G. Moon, “Intravesical prostatic protrusion is a risk factor for bladder stone in patients with benign prostatic hyperplasia,” Urology, vol. 84, no. 5, pp. 1026-1029, Nov. 2014.
R. C. Flanigan, D. J. Reda, J. H. Wasson, R. J. Anderson, M. Abdellatif, and R. C. Bruskewitz, “5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study,” J. Uro., vol. 160, no. 1, pp. 12-17, Jul. 1998.
A. Ahmed, “Sonographic parameters predicting the outcome of patients with lower urinary tract symptoms/benign prostatic hyperplasia treated with alpha1-adrenoreceptor antagonist,” Urology, vol. 88, pp. 143-148, Nov. 2016.
Q. Liu, Y. Zhu, J. Liu, J. Qi, and J. Kang, “Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH),” Int. Urol. Nephrol., vol. 49, no. 3, pp. 399-404, Mar. 2017.
K. Hirayama, K. Masui, A. Hamada, Y. Shichiri, N. Masuzawa, and S. Hamada, “Evaluation of intravesical prostatic protrusion as a predictor of dutasteride-resistant lower urinary tract symptoms/benign prostatic enlargement with a high likelihood of surgical intervention,” Urology, vol. 86, no. 3, pp. 565-569, Sep. 2015.
R. T. Puthenveetil, D. Baishya, S. Barua, and D. Sarma, “Implication of ultrasound bladder parameters on treatment response in patients with benign prostatic hyperplasia under medical management,” Asian J. Urol., vol. 2, no. 4, pp. 233-237, Oct. 2015.
Y. H. Tan, and K. T. Foo, “Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention,” J. Urol., vol. 170, no. 6, pp. 2339-2341, Dec. 2003.
X. D. Li, Y. P. Wu, Z. B. Ke, T. T. Lin, S. H. Chen, X. Y. Xue, N. Xu, and Y. Wei, “Predictors of postoperative lower urinary tract symptoms improvements in patient with small-volume prostate and bladder outlet obstruction,” Ther. Clin. Risk Manag., vol. 15, pp. 1291-1304, Nov. 2019.
X. Chen, Q. Man, X. Wei, X. Ren, G. Li, Z. Lu, X. Zhang, and C. Qin, “Predictive value of preoperative comprehensive evaluation on the efficacy of HoLEP,” Transl. Androl. Urol., vol. 9, no. 4, pp. 1603-1610, Aug. 2020.
J. Park, C. H. Park, I. Sun, S. Y. Cho, M. C. Cho, H. Jeong, and H. Son, “Preoperative transrectal ultrasonographic findings can predict the improvement of the peak urinary flow rate after surgical treatment of benign prostatic enlargement in patients with lower urinary tract symptoms,” J. Urol., vol. 197, no. 4S, pp. e513-514, Apr. 2017.
J. H. Wee, Y. S. Choi, W. J. Bae, S. J. Kim, H. J. Cho, S. H. Hong, J. Y. Lee, and S. W. Kim, “Influence of intravesical prostatic protrusion on preoperative lower urinary tract symptoms and outcomes after 120 w high performance system laser treatment in men with benign prostatic hyperplasia,” Korean J. Urol., vol. 53, no. 7, pp. 472-477, Jul. 2012.
M. Meira, A. M. de Assis, A. M. Moreira, A. A. Antunes, F. C. Carnevale, and M. Srougi, “Intravesical prostatic protrusion does not influence the efficacy of prostatic artery embolization” J. Vasc. Interv. Radiol., vol.32, no. 1, pp. 106-112, Jan. 2021.
S. Z. Maron, A. Sher, J. Kim, R. A. Lookstein, A. R. Rastinehad, and A. Fischman, “Effect of median lobe enlargement on early prostatic artery embolization outcomes,” J. Vasc. Interv. Radiol., vol. 31, no. 3, pp. 370-377, Mar. 2020.
L. Topazio, C. Perugia, C. De Nunzio, G. Gaziev, V. Iacovelli, D. Bianchi, G. Vespasiani, and E. F. Agrò, “Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study,” BMC urol., vol. 18, no. 1, pp. 1-5, Dec. 2018.
O. S. Sharis, M. Z. Zulkifli, and A. H. Hamzaini, “Predicting outcome of trial of voiding without catheter in acute urinary retention with intravesical prostatic protrusion” Malays. J. Med. Sci., vol. 20, no. 1, pp. 56-59, Jan. 2013.
H. Y. Tiong, M. J. Tibung, M. Macalalag, M. K. Li, and D. Consigliere, “Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia” Urol. Int., vol. 83, no. 1, pp. 44-48, Jul. 2009.
Z. Liu, J. Chen, and Q. Lu Q, “Impact of intravesical prostatic protrusion and pathological type on transurethral resection of the prostate for benign prostatic hyperplasia.” Biomed. Res., vol. 28, no. 9, pp. 8367-8371, Sept. 2017.
T. Huang, J. Qi, Y. J. Yu, D. Xu, Y. Jiao, J. Kang, Y. Q. Chen, and Y. K. Zhu, “Predictive value of resistive index, detrusor wall thickness and ultrasound estimated bladder weight regarding the outcome after transurethral prostatectomy for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction,” Int. J. Urol., vol. 19, no. 4, pp. 343-350, Apr. 2012.
J. W. Lee, J. H. Ryu, T. K. Yoo, S. S. Byun, Y. J. Jeong, and T. Y. Jung, “Relationship between intravesical prostatic protrusion and postoperative outcomes in patients with benign prostatic hyperplasia,” Korean J. Urol., vol. 53, no. 7, pp. 478-482, Jul. 2012.
S. C. H. Yu, C. C. M. Cho, E. H. Y. Hung, J. Zou, B. T. Y. Yuen, L. Shi, and et al, “Thickness-to-height ratio of intravesical prostatic protrusion predicts the clinical outcome and morbidity of prostatic artery embolization for benign prostatic hyperplasia,” J. Vasc. Interv. Radiol., vol. 30, no. 11, pp. 1807-1816, Oct. 2019.
This work is licensed under a Creative Commons Attribution 4.0 International License.